Article
The Past, Present and Future of Flow Cytometry in Central Nervous System Malignancies
26 Jan 2021
Abstract excerpt
Central nervous system malignancies (CNSMs) are categorized among the most aggressive and deadly types of cancer. The low median survival in patients with CNSMs is partly explained by the objective difficulties of brain surgeries as well as by the acquired chemoresistance of CNSM cells. Flow Cytometry is an analytical technique with the ability to quantify cell phenotype and to categorize cell populations on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
